Search Results 4701-4710 of 36769 for oral

  1. Publications - Matthew A. Zarka, M.D. - Mayo Clinic

    ... Oral Tongue. Head Neck Pathol. 2021 Jun; 15 (2):509-522 Epub 2020 Oct 03. View PubMed; Sanchez JA, Portillo S, Zarka MA, Snedden D, Pyle D, Goodman H, Hayes ...

  2. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  5. A Study To Evaluate The Effectiveness Of IDCT (Intradiscal Cell Therapy) In Subjects With One Level, Symptomatic Mild To Moderate Lumbar Degenerative Disc Disease - Mayo Clinic

    ... oral contraceptive, implant, injectable, indwelling intrauterine device, sexual abstinence, condoms, or a vasectomized partner).-. Exclusion Criteria ...

  6. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  7. The future will be personalized: Accelerating microbiome research - Mayo Clinic News Network

    A collaborative study with the University of Paris identified strains of oral microbiota that contribute to the risk of colorectal cancer by introducing ...

  8. A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

    Participant is able to take oral medication. Registration Exclusion Criteria: Participant has had a prior allogeneic transplant. Participant has Karnofsky ...

  9. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

    ... oral contraceptive, or have a vasectomized partner with confirmed azoospermia) within 30 days before study entry and throughout the entire study period and ...

  10. A Study of Bezisterim (NE3107) in Adults with Long COVID - Mayo Clinic

    The purpose of this study is to evaluate the efficacy, safety, and tolerability of bezisterim (NE3107) oral capsules compared with matching placebo, in ...